Alpha Tau Medical (DRTSW) Share-based Compensation (2021 - 2026)
Alpha Tau Medical (DRTSW) posted Share-based Compensation of $9.4 million for Q4 2025, down 39.4% sequentially from $15.4 million in Q2 2025, and down 22.79% YoY from $12.1 million in Q4 2024.
Alpha Tau Medical (DRTSW) Share-based Compensation (2021 - 2026) Analysis & Trends
Alpha Tau Medical has reported Share-based Compensation for 5 years, with the latest figure at $9.4 million in Q4 2025.
- Quarterly Share-based Compensation fell 22.79% year-over-year to $9.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.4 million (down 22.79% YoY) and the FY2025 annual result came in at $10.6 million, down 12.36% from the prior year.
- Share-based Compensation eased to $9.4 million in Q4 2025 per DRTSW's latest filing, from $15.4 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $19.5 million in Q2 2023 and troughed at $145000.0 in Q1 2021.
- A 5-year average of $9.3 million and a median of $10.7 million in 2024 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2022 and 2025: Share-based Compensation jumped 1266.9% in 2022, then declined 22.79% in 2025.
- Over 5 years, Share-based Compensation stood at $2.3 million in 2021, then slumped by 35.83% to $1.5 million in 2022, then jumped by 884.01% to $14.4 million in 2023, then fell by 15.85% to $12.1 million in 2024, then slipped by 22.79% to $9.4 million in 2025.
- According to Business Quant data, Share-based Compensation over the past three periods registered $9.4 million, $15.4 million, and $12.1 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 86.63 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 28.05 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 41.25 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Alpha Tau Medical | 383.00 Mn | 200.58 Mn | - | 13.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.95 Mn |
| Jun 30, 2026 | 13.95 Mn |
| Dec 31, 2025 | 9.35 Mn |
| Dec 31, 2025 | 9.35 Mn |
| Jun 30, 2025 | 15.44 Mn |
| Jun 30, 2025 | 15.44 Mn |
| Dec 31, 2024 | 12.11 Mn |
| Dec 31, 2024 | 12.11 Mn |
| Jun 30, 2024 | 16.28 Mn |
| Jun 30, 2024 | 16.28 Mn |
| Dec 31, 2023 | 14.40 Mn |
| Dec 31, 2023 | 14.40 Mn |
| Jun 30, 2023 | 19.51 Mn |
| Jun 30, 2023 | 19.51 Mn |
| Jun 30, 2022 | 1.46 Mn |
| Jun 30, 2022 | 1.46 Mn |
| Mar 31, 2022 | 1.98 Mn |
| Mar 31, 2022 | 1.98 Mn |
| Dec 31, 2021 | 2.28 Mn |
| Dec 31, 2021 | 2.28 Mn |